Newer agents continue to be developed, and these offer clinicians and patients additional options for managing colon cancer.
Bisphosphonates, along with a healthy lifestyle and adequate intake
of calcium and vitamin D, are the treatment of choice in breast cancer
patients with bone loss and accelerated bone turnover.